BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND ATIC, IMPCHASE, 471, ENSG00000138363, AICARFT, P31939, PURH AND Prognosis
19 results:

  • 1. prognosis of pancreaticoduodenectomy in octogenarians for pancreatic ductal adenocarcinoma with propensity score matched analysis.
    Jeong H; Lim SY; Jeon HJ; Yoon SJ; Kim H; Han IW; Heo JS; Shin SH
    ANZ J Surg; 2023 Nov; 93(11):2655-2663. PubMed ID: 37658597
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Negative p53 Expression Confers Worse prognosis in Patients With Resected pancreatic Ductal Adenocarcinoma: Research Focused on Reinterpretation of Immunohistochemical Staining.
    Li B; Wang Y; Wang J; Zhang G; Yin X; Wang H; Jiang H; Jin G; Guo S
    Pancreas; 2022 Oct; 51(9):1217-1224. PubMed ID: 37078948
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy.
    Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Takata N; Tsuruoka S; Uwatsu K; Kido T
    Med Sci (Basel); 2023 Feb; 11(1):. PubMed ID: 36810484
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluating the Significance of Pancreatobiliary Fluorescence In Situ Hybridization Polysomy on prognosis in De Novo Cholangiocarcinoma.
    Ji H; Barr Fritcher EG; Yin J; Bainter TM; Zemla TJ; Gores GJ; Halling KC; Kipp BR; Roberts LR
    Clin Transl Gastroenterol; 2022 Oct; 13(10):e00523. PubMed ID: 36000989
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Impact of adjuvant chemotherapy on prognosis in intrahepatic cholangiocarcinoma patients underwent radical resection].
    Su JB; Zhang JW; Chen C; Qiu YH; Wu H; Song TQ; He Y; Mao XH; Zhai WL; Cheng ZJ; Li JD; Si SB; Cai ZQ; Geng ZM; Tang Z
    Zhonghua Wai Ke Za Zhi; 2022 Apr; 60(4):356-362. PubMed ID: 35272427
    [No Abstract]    [Full Text] [Related]  

  • 6. atic inhibits autophagy in hepatocellular cancer through the AKT/FOXO3 pathway and serves as a prognostic signature for modeling patient survival.
    Zhang H; Xia P; Liu J; Chen Z; Ma W; Yuan Y
    Int J Biol Sci; 2021; 17(15):4442-4458. PubMed ID: 34803509
    [No Abstract]    [Full Text] [Related]  

  • 7. Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study.
    Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
    Radiat Oncol; 2021 Nov; 16(1):225. PubMed ID: 34801042
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Outcomes Between a Minimally Invasive and Open Extended Cholecystectomy for T2 Gallbladder cancer: A Propensity Score Matching Analysis.
    Lee W; Kim KM; Kwak BJ; Park Y; Jun E; Song KB; Hwang DW; Kim SC; Lee JH
    J Laparoendosc Adv Surg Tech A; 2022 May; 32(5):538-544. PubMed ID: 34382818
    [No Abstract]    [Full Text] [Related]  

  • 9. Comprehensive histological evaluation with clinical analysis of venous invasion in pancreatic ductal adenocarcinoma: From histology to clinical implications.
    Lee SJ; Sung YN; Kim SJ; Shin S; Cho H; Hruban RH; Hong SM
    Pancreatology; 2020 Oct; 20(7):1486-1494. PubMed ID: 32948429
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients.
    Barth DA; Brenner C; Riedl JM; Prinz F; Klocker EV; Schlick K; Kornprat P; Lackner K; Stöger H; Stotz M; Gerger A; Pichler M
    Cancer Med; 2020 Aug; 9(15):5473-5479. PubMed ID: 32537935
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Para-aortic lymph node metastasis detected intraoperatively by systematic frozen section examination in pancreatic head adenocarcinoma: is resection improving the prognosis?
    Collard M; Voron T; Svrcek M; Ahmed O; Balladur P; Hor T; André T; Paye F
    HPB (Oxford); 2020 Nov; 22(11):1604-1612. PubMed ID: 32179009
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic value of 18F-FDG PET /CT metabolic parameters in patients with locally advanced pancreatic cancer treated with stereotactic body radiation therapy.
    Ren S; Zhu X; Zhang A; Li D; Zuo C; Zhang H
    Cancer Imaging; 2020 Mar; 20(1):22. PubMed ID: 32156306
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. FGFR1 expression defines clinically distinct subtypes in pancreatic cancer.
    Haq F; Sung YN; Park I; Kayani MA; Yousuf F; Hong SM; Ahn SM
    J Transl Med; 2018 Dec; 16(1):374. PubMed ID: 30593273
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Metabolic and lifestyle risk factors for acute pancreatitis in Chinese adults: A prospective cohort study of 0.5 million people.
    Pang Y; Kartsonaki C; Turnbull I; Guo Y; Yang L; Bian Z; Chen Y; Millwood IY; Bragg F; Gong W; Xu Q; Kang Q; Chen J; Li L; Holmes MV; Chen Z
    PLoS Med; 2018 Aug; 15(8):e1002618. PubMed ID: 30067849
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Association between Recipient IL-15 Genetic Variant and the prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation.
    Zhang T; Liu Y; Peng X; Fan J; Peng Z
    Dis Markers; 2017; 2017():1754696. PubMed ID: 29162948
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Platelet × CRP Multiplier Value as an Indicator of Poor prognosis in Patients With Resectable pancreatic cancer.
    Miyamoto R; Oda T; Hashimoto S; Kurokawa T; Kohno K; Akashi Y; Ohara Y; Yamada K; Enomoto T; Ohkohchi N
    Pancreas; 2017 Jan; 46(1):35-41. PubMed ID: 27984485
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Impact of preoperative diabetes on long-term survival after curative resection of pancreatic adenocarcinoma: a systematic review and meta-analysis.
    Walter U; Kohlert T; Rahbari NN; Weitz J; Welsch T
    Ann Surg Oncol; 2014 Apr; 21(4):1082-9. PubMed ID: 24322532
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.
    Bachet JB; Maréchal R; Demetter P; Bonnetain F; Cros J; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
    Eur J Cancer; 2013 Aug; 49(12):2643-53. PubMed ID: 23726265
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma.
    Bachet JB; Maréchal R; Demetter P; Bonnetain F; Couvelard A; Svrcek M; Bardier-Dupas A; Hammel P; Sauvanet A; Louvet C; Paye F; Rougier P; Penna C; Vaillant JC; André T; Closset J; Salmon I; Emile JF; Van Laethem JL
    Ann Oncol; 2012 Sep; 23(9):2327-2335. PubMed ID: 22377565
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.